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248* Using an individualized treadmill protocol to assess maximal
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Introduction: Although the 6 minute walk test (6 MWT) is an established, safe
and well tolerated method of assessing sub-maximal exercise capacity in CF, it
requires adequate space and may not easily represent activities of daily living. We
therefore examined the utility of a simple individualized treadmill protocol to assess
metabolic capacity, using the maximal steady state (MSS) and compared it with the
6 MWT.
Patients and Methods: Paired tests were carried out on 216 adult CF patients (mean
age 25 years, 106 male): MSS treadmill capacity was compared with a 6 MWT
around a 20 metre course. Patients warmed up for 3 minutes at a comfortable
pace before using a combination of speed and incline to incrementally reach
their highest sustainable exercise intensity, without experiencing undue fatigue and
without encouragement, for a minimum of 6 minutes. ACSM metabolic equations
were used to estimate O2 cost and calculate a metabolic equivalent (MET) value
for the exercise.
Results: There was a strong correlation between MSS MET values and 6MWT
scores (r2 = 0.83, P< 0.0001). Furthermore, those who were only able to sustain a
low steady state on the treadmill were better able to replicate and frequently surpass
their efforts on the 6MWT. Patients achieving higher steady state intensity are likely
to have been hindered by the increased anaerobic demands of slowing and reversing
direction every 20 metres.
Conclusions: The use of a simple sub-maximal treadmill test may aid clinicians to
better relate a patient’s functional capacity to the demands of leisure, occupation
and daily living as well as to help chart changes in physical ﬁtness and clinical
status.
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Introduction: The 6 minute walk test (6MWT) is a useful tool in assessing exercise
capacity in CF patients, where a score of <400 metres may indicate suitability
for lung transplantation. However, in clinics with space constraints, such tests are
difﬁcult, and they may not easily represent activities of daily living. We examined
an alternative means of assessment, the sub-maximal treadmill test, and compared
it with the 6MWT as a guide to assessment for transplantation.
Patients and Methods: 26 patients (mean age 27 years, 13 male) considered for
transplant referral under went an individualised treadmill protocol exercise test that
represented their maximal sustainable effort without undue fatigue or over exertion
for a minimum of 6 minutes. ACSM metabolic equations were used to estimate
O2 cost and calculate a Metabolic Equivalent (MET) value for the exercise. These
were compared with corresponding 6MWT performed over a level 20 metre course.
We also reviewed pulmonary function (FEV1) and nutritional status (BMI) at the
time.
Results: There was a strong correlation between treadmill scores (mean 2.9 METs)
and the corresponding 6MWT (mean 392 metres) (r2 = 0.905; P< 0.0001). There
was no correlation between either sub-maximal exercise test with FEV1 or
with BMI.
Conclusions: A sub-maximal treadmill protocol is a useful tool to aid clinicians
regarding the timing of a referral for transplantation. The mean six-minute walk
distance achieved by the patients in this study relates well to previous studies. The
corresponding mean treadmill score of 2.9 METs might indicate a threshold that
below which a CF patient is considered for suitable for lung transplantation referral.
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Background: Cardiopulmonary exercise testing represents the gold standard to
evaluate exercise capacity but its use in the paediatric age is limited. In this age
group ﬁeld tests can be used to assess exercise tolerance as well. However despite
their simplicity these tests are not widely used in children and their role in the
clinical setting is still to be determined.
Objectives: The purpose of this study was to compare Six Minute Walking
Test (6MWT), Step Test (ST) and Modiﬁed Shuttle Walk Test (MSWT) in order to
establish the most useful method to assess exercise capacity in children.
Methods: 20 patients with CF (13F, 7M aged 6−16 yrs) and normal lung function
to moderate airway obstruction were recruited. All subjects performed 6MWT, ST
and MSWT on different days. Outcome measures were distance walked or steps
completed, SpO2, heart rate (HR), respiratory rate (RR) and visual analogue score
of dyspnea and muscle fatigue, before and after performance.
Results: DHR was higher in MSWT than 6MWT (p< 0.01) and ST (p< 0.01).
Dyspnea score at the end of the test was higher in MSWT than 6MWT (p< 0.0001)
and ST (p< 0.0001). SpO2 at the end of the test was lower in MSWT than 6MWT
(p< 0.001) and ST (p< 0.001). In addition, the distance walked was higher in
MSWT than 6MWT (p< 0.01). The FEV1 predicted values were signiﬁcantly
correlated with performances in MSWT and 6MWT.
Conclusion: This study shows that the MSWT when compared to 6MWT and ST
is the most useful method to detect the maximal exercise capacity in CF children.
These results may be explained at least in part by the fact that MSWT gives children
an easier way to control their performance.
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Introducion: Children need a good level of aerobic capacity to participate in daily
life. Cardiopulmonary exercise testing (CPET) is accepted as gold standard to study
a patient’s level of aerobic capacity. Higher level of cardiorespiratory endurance is
associated with proﬁciency in fundamental movement skills.
Measuring motor health related physical ﬁtness with a CPET is expensive and
performance (ﬁeld) tests are a valid and inexpensive alternative.
The purpose of this study was to examine the association between the Bruininks–
Oseretsky test of Motor Proﬁciency (BOT-2) (Agility and Strength) and two
cardiopulmonary exercise protocols: ‘classic’ step protocol and Steep Ramp (SR)
protocol, in children with cystic ﬁbrosis (CF).
Methods: Seventeen CF adolescents (9 males, 8 females; mean age 14.7, mean
FEV1 predicted 80%, participating the MOVIT-study (Mucoviscidosis en Ontsteking,
Variabiliteit door Inspanning en Training) performed two CPET protocols and
BOT-2.
Results: Pearson correlation between BOT-2 and CPET was moderate to good for
VO2peakl/min: r = 0.69; VO2peakml/min/kg: r = 0.77; Wpeak: r = 0.65 and Wpeakkg:
r = 0.64.
Spearman’s rank correlation was moderate to good between BOT-2 (domain 6)
and SR-VO2peak(l/min): rs = 0.54; SR-VO2peak(ml/min/kg): rs = 0.62; SR-Wpeakkg:
rs = 0.51; between BOT-2 domain 8 Point score and SR-VO2peak ml/min/kg:
rs = 0.58.
Conclusion: Measuring physical ﬁtness with a performance test and a CPET in
CF children is useful. BOT-2 seems to reﬂect better the daily activity level of
children with CF, this daily activity level seems not to be in conformity with the
aerobic capacity of these children.
